trending Market Intelligence /marketintelligence/en/news-insights/trending/alrmtcdqdeburj8skl0jvw2 content esgSubNav
In This List

RHS shareholders approve acquisition by PerkinElmer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


RHS shareholders approve acquisition by PerkinElmer

Australia's RHS Ltd. said shareholders approved the scheme of arrangement for PerkinElmer Inc.'s purchase of the company.

Under the scheme, Waltham, Mass.-based PerkinElmer will acquire 89,920,483 outstanding RHS shares.

The scheme is scheduled to be implemented June 14, following approval by the Federal Court of Australia.

RHS develops and markets biotechnology technologies.